Brief: Neurovive Q4 pretax loss doubles yr/yr

Abliva AB

21/02/2017 07:30

Feb 21 (Reuters) - Neurovive Pharmaceutical AB  NVP.ST  
    * Q4 loss before tax was SEK 14.6 million (7.4) 
 
Source text for Eikon:  ID:nWkr2JYPwr  
Further comOpany coverage:  NVP.ST  
 
 (Stockholm Newsroom) 
 ((stockholm.newsroom@thomsonreuters.com; +46 (0)8-700 10 10;))